Conference abstractPublished 2017
Can we target amino acid metabolism to affect brain tumor growth?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Brain tumors cause major morbidity/mortality. Glioblastoma (GBM) in adults and medulloblastoma in children are major types of clinically aggressive high-grade CNS malignancies. These have increased uptake of radio-labeled aminoacids (AA) used for PET scans. Central amino-acid Glutamine (Gln) is crucial for growth of brain tumors. Nevertheless, there arenâÂ?Â?t clinically effective pharmaceutical interventions against AA metabolism of brain tumors. In contrary, anti-metabolites like bacterial enzyme asparaginase (ASNase, which effectively depletes asparagine and Gln in blood and CSF) are successfully used to treat acute leukemias. Thus, we aimed to study if manipulation of AA metabolism may have a role in developing therapeutics against brain tumors. Methodology & Theoretical Orientation: We conducted series of analyses on large brain tumor databases containing molecular signatures and clinical outcomes. In addition, using ASNase as a research tool, we carried out series of pre-clinical investigations on glioma cell-lines and on mice that harbor medulloblastomas. Findings: We have shown that lower co-expressions of BCAT1, ASNS and GLS are associated with better outcome in 66 newly diagnosed GBM patients (UCLA-probesetanalyzer database). Three additional GBM datasets (r2.amc.nl) showed that at least 4 additional AA-related enzymes-which have higher expression in GBM, also predict poor outcome in 504 GBM patients (TCGA database). Several of these enzymes have differential expression in pediatric brain tumors, including subtypes of medulloblastomas. Mouse models of medulloblastomas demonstrated anti-tumor efficacy of E. coli-ASNase+TMZ against DAOY-SQ model and of Erwinia Chrysanthemi-ASNase, which shows preliminary efficacy in SMO/SMO spontaneous medulloblastoma model. All ASNase formulations showed in vitro activity against glioma cells with variable IC50s. Conclusion & Significance: Our studies support the concept that AA metabolism plausibly harbors targetable nodes, which can be studied for new anti-metabolite therapeutics development for brain tumors. They provide opportunities for combined therapies due to less myelosuppressive toxicity profile.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroscience and Neuropharmacology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Eduard H Panosyan”
- BylineArticles whose byline prints “Joseph L Lasky”
